Education / Graduate Medical Education / Prospective Fellows / Infectious Diseases Fellowship / Research / Peer Reviewed Publications

Recent Peer Reviewed Publications

1. Whitaker JA
2. Collins MH
3. Rebolledo PA
4. Dobrzynski D
5. Samanovic MI
6. Hoft D
7. Stephens DS
8. Rostad CA
Future Goals and Long-term Vision of the Infectious Diseases Clinical Research Consortium/Vaccine and Treatment Evaluation Unit Network.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 81(Supplement_2), pp. S137-S146. 2025 Oct 10.
1. Dobrzynski DM
2. Graciaa DS
3. Babu TM
4. Coler RN
5. Paulsen GC
6. Hoft DF
7. Frey SE
8. Edwards KM
9. Jackson LA
10. Chen WH
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 81(Supplement_2), pp. S125-S136. 2025 Oct 10.
1. Mbuya W
2. Horvath A
3. Held K
4. Maganga L
5. Hoelscher M
6. Bekker LG
7. Duerr A
8. Moodie Z
9. Churchyard G
10. Keefer MC
11. Viegas E
12. Moog C
13. Geldmacher C
14. Chachage M
Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses.; Frontiers in immunology; Vol 16, pp. 1601865. 2025 Sep 23.
1. O'Halloran A
2. Habeck JW
3. Gilmer M
4. Threlkel R
5. Chai SJ
6. Hall B
7. Armistead I
8. Alden NB
9. Meek J
10. Yousey-Hindes K
11. Openo KP
12. Witt LS
13. Monroe ML
14. Ryan PA
15. Leegwater L
16. Kim S
17. McMahon M
18. Lynfield R
19. Harbi K
20. Khalifa M
21. McCahon C
22. Barney G
23. Anderson BJ
24. Felsen CB
25. Tesini BL
26. Moran NE
27. Ingabire-Smith D
28. Sutton M
29. Hendrick MA
30. Schaffner W
31. Talbot HK
32. George A
33. Zahid H
34. Garg S
35. Bozio CH
Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season.; MMWR. Morbidity and mortality weekly report; Vol 74(34), pp. 529-537. 2025 Sep 11.
1. Diemert DJ
2. Graciaa DS
3. Zhang B
4. Rouphael NG
5. Branche AR
6. Martin TCS
7. Jackson LA
8. Presti RM
9. Kamidani S
10. Mahgoub SM
11. Babu TM
12. Magaret CA
13. Simon V
14. van Bakel H
15. Roberts PC
16. Beigel JH
17. Gilbert PB
18. Follmann D
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial.; Vaccine; Vol 64, pp. 127718. 2025 Sep 09.
1. Parks KR
2. Moodie Z
3. Allen MA
4. Yen C
5. Furch BD
6. MacPhee KJ
7. Ozorowski G
8. Heptinstall J
9. Hahn WO
10. Zheng Z
11. Lu H
12. Grant S
13. Domin E
14. Duff MO
15. Seese A
16. Marini-Macouzet C
17. Ballweber-Fleming L
18. Lee WH
19. Cottrell CA
20. Liguori A
21. Georgeson E
22. Alavi N
23. Kubitz M
24. Phelps N
25. Seaton KE
26. Cohen KW
27. Anderson MA
28. Mondal K
29. Laufer DS
30. Kublin JG
31. Ward AB
32. Hyrien O
33. De Rosa SC
34. Himansu S
35. Leav B
36. Reuter C
37. Tomaras GD
38. Montefiori D
39. Walsh SR
40. Frank I
41. Sobieszczyk ME
42. Goepfert PA
43. Stephenson KE
44. Baden LR
45. Van Tieu H
46. Keefer MC
47. Clark J
48. Riddler SA
49. Schief WR
50. McElrath MJ
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.; Science translational medicine; Vol 17(809), pp. eady6831. 2025 Jul 30.
1. Wang D
2. Pham HT
3. Chai S
4. Hoover C
5. Armistead I
6. Kawasaki B
7. Yousey-Hindes KM
8. Meek J
9. Witt LS
10. Openo KP
11. Brooks A
12. Rojewski S
13. Henderson JJ
14. Martin E
15. Mumm E
16. Salazar-Sanchez Y
17. Paloma Shaw Y
18. Keating F
19. Rowe A
20. Popham K
21. Tesini BL
22. Novak A
23. Sutton M
24. Schaffner W
25. Talbot HK
26. Hill M
27. Zahid H
28. Havers FP
29. Patton ME
Characteristics of Children Aged 0 to 23 Months Hospitalized With Respiratory Syncytial Virus.; Pediatrics. 2025 Jul 25.
1. Conley H
2. Oh SY
3. Garrett N
4. Kublin J
5. Monaco CL
6. Watts S
7. Jha S
8. Ferrari G
9. Tomaras GD
10. Geraghty DE
11. Chan C
12. Pollara J
IgG and Fc receptor genetic variation associates with functional antibody responses in a DNA and protein candidate HIV vaccine trial.; Journal of acquired immune deficiency syndromes (1999). 2025 Jul 24.
1. Samoriski C
2. Chu CY
3. Falsey AR
4. Peterson D
5. Bhattacharya S
6. Croft DP
7. Branche AR
8. Peasley M
9. Baran A
10. Corbett A
11. Ashton J
12. Mariani TJ
13. Walsh EE
Clinical Features and Gene Expression Patterns in Adults Hospitalized With Respiratory Syncytial Virus and Human Metapneumovirus Infection.; The Journal of infectious diseases; Vol 232(Supplement_1), pp. S37-S46. 2025 Jul 16.
1. Branche AR
2. Edwards KM
Review: Knowledge Gained and Gaps in Understanding in the 25 Years Since Human Metapneumovirus Was First Identified as a Cause of Human Disease.; The Journal of infectious diseases; Vol 232(Supplement_1), pp. S1-S9. 2025 Jul 16.
1. Walsh EE
2. Peasley M
3. Branche AR
4. Falsey AR
Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection.; The Journal of infectious diseases; Vol 231(6), pp. e1146-e1150. 2025 Jul 11.
1. Branche AR
2. Falsey AR
3. Saiman L
4. Alba L
5. Peterson D
6. Wang L
7. Finelli L
8. Walsh EE
Respiratory Syncytial Virus Risk Assessment in Adults: Implications for Vaccine Recommendations Beyond Age.; Open forum infectious diseases; Vol 12(7), pp. ofaf394. 2025 Jul 02.
1. Sudnik P
2. Walsh EE
3. Branche AR
4. Islam M
5. Falsey AR
Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized with RSV.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025 Jun 12.
1. Jenkins EN
2. Gold JAW
3. Benedict K
4. Lockhart SR
5. Berkow EL
6. Dixon T
7. Shack SL
8. Witt LS
9. Harrison LH
10. Seopaul S
11. Correa MA
12. Fitzsimons M
13. Jabarkhyl Y
14. Barter D
15. Czaja CA
16. Johnston H
17. Markus T
18. Schaffner W
19. Gross A
20. Lynfield R
21. Tourdot L
22. Nadle J
23. Roland J
24. Escutia G
25. Zhang AY
26. Gellert A
27. Hurley C
28. Tesini BL
29. Phipps EC
30. Davis SS
31. Lyman M
Population-Based Active Surveillance for Culture-Confirmed Candidemia - 10 Sites, United States, 2017-2021.; Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002); Vol 74(4), pp. 1-15. 2025 May 29.
1. Croft DP
2. Johnston CJ
3. Branche AR
4. Rich DQ
5. Hopke PK
6. Thevenet-Morrison K
7. Thurston SW
8. Jusko TA
9. Islam MR
10. Bunce C
11. Keefer MC
12. Walsh EE
13. Falsey AR
Ambient air pollution exposure and effects on neutralizing antibody titers following SARS-CoV-2 vaccination in adults.; PLOS global public health; Vol 5(5), pp. e0004609. 2025 May 12.